Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America

Clin Infect Dis. 2014 May;58(9):1308-11. doi: 10.1093/cid/ciu094. Epub 2014 Feb 27.

Abstract

In May 2013, a revised and updated version of the Centers for Disease Control and Prevention/National Institutes of Health/HIV Medicine Association Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents was released online. These guidelines, since their inception in 1989, have been widely accessed in the United States and abroad. These guidelines have focused on the management of HIV/AIDS-related opportunistic infections that occur in the United States. In other parts of the world, the spectrum of complications may be different and the resources available for diagnosis and management may not be identical to those in the United States. The sections that have been most extensively updated are those on immune reconstitution inflammatory syndrome, tuberculosis, hepatitis B, hepatitis C, human papillomavirus, and immunizations. The guidelines will not be published in hard copy form. This document will be revised as needed throughout each year as new data become available.

Keywords: HIV/AIDS; guideline; online; opportunistic infections; revision.

Publication types

  • Guideline

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / prevention & control*
  • Adolescent
  • Adult
  • Centers for Disease Control and Prevention, U.S.
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Hepatitis B / complications
  • Hepatitis B / drug therapy
  • Hepatitis B / prevention & control
  • Hepatitis C / complications
  • Hepatitis C / drug therapy
  • Hepatitis C / prevention & control
  • Humans
  • Immune Reconstitution Inflammatory Syndrome / complications
  • Immune Reconstitution Inflammatory Syndrome / drug therapy
  • Immune Reconstitution Inflammatory Syndrome / prevention & control
  • National Institutes of Health (U.S.)
  • Papillomavirus Infections / complications
  • Papillomavirus Infections / drug therapy
  • Papillomavirus Infections / prevention & control
  • Tuberculosis / complications
  • Tuberculosis / drug therapy
  • Tuberculosis / prevention & control
  • United States